APP and Alzheimer disease: Knockdown models of BACE1-AS by siRNA resulted in reduced BACE1, APP production, and tau phosphorylation in the hippocampus in SAMP8 mice, a neurodegeneration model used to study AD (Zhang et al., 2018).